Nuwellis, Inc. (NUWE)
NASDAQ: NUWE · Real-Time Price · USD
2.770
+0.002 (0.06%)
Nov 4, 2025, 11:17 AM EST - Market open
Nuwellis Revenue
Nuwellis had revenue of $1.73M in the quarter ending June 30, 2025, a decrease of -21.38%. This brings the company's revenue in the last twelve months to $8.32M, down -7.72% year-over-year. In the year 2024, Nuwellis had annual revenue of $8.74M, down -1.40%.
Revenue (ttm)
$8.32M
Revenue Growth
-7.72%
P/S Ratio
0.02
Revenue / Employee
$218,895
Employees
38
Market Cap
2.50M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.74M | -124.00K | -1.40% |
| Dec 31, 2023 | 8.86M | 321.00K | 3.76% |
| Dec 31, 2022 | 8.54M | 622.00K | 7.85% |
| Dec 31, 2021 | 7.92M | 480.00K | 6.45% |
| Dec 31, 2020 | 7.44M | 1.93M | 35.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.11B |
NUWE News
- 12 days ago - Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025 - GlobeNewsWire
- 5 weeks ago - Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex® - GlobeNewsWire
- 6 weeks ago - Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration - GlobeNewsWire
- 6 weeks ago - Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment - GlobeNewsWire
- 2 months ago - Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio - GlobeNewsWire
- 2 months ago - Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management - GlobeNewsWire
- 2 months ago - Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter - GlobeNewsWire
- 2 months ago - Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company - GlobeNewsWire